Clinical Implications of “Tailored” Antiplatelet Therapy in Patients With Chronic Total Occlusion

BACKGROUND: Clopidogrel nonresponsiveness is a prognostic marker after percutaneous coronary intervention. Prasugrel and ticagrelor provide a better platelet inhibition and represent the first‐line antiplatelet treatment in acute coronary syndrome. We sought to assess the prognostic impact of high p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Am Heart Assoc
Egile Nagusiak: De Gregorio, Maria Grazia, Marcucci, Rossella, Migliorini, Angela, Gori, Anna Maria, Giusti, Betti, Vergara, Ruben, Paniccia, Rita, Carrabba, Nazario, Marchionni, Niccolò, Valenti, Renato
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7070214/
https://ncbi.nlm.nih.gov/pubmed/32067582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.014676
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak